The new science of accelerating innovation

Omics + big data + biomarker-guided drug development. It’s a new reality, bringing unprecedented abilities to interrogate and translate biological information—and unprecedented opportunities for life sciences companies to achieve their goals faster and more cost-effectively. This fundamental shift requires a new approach to drug development. Precision for Medicine is leading the way.

Explore our services
  • Translational Informatics and Biometrics
  • Oncology Solutions
  • Biomaterials
  • Specialty Lab Services
  • Diagnostics and Medical Device Solutions
  • Rare and Orphan Solutions
« Back

Precision for Medicine can help you find and extract the long-term value of innovative drugs

We develop your assays and manage global logistics, speeding to actionable answers. We use biomarkers to stratify patients, incomparably improving your R&D efficiency and success. We manage every aspect of your clinical trials from sites to biomarkers to diagnostics, all under a single roof. And we’re constantly adding services and expertise under that roof to support medical innovators — like our recent acquisition of ETHOS Health Communications, specializing in the interpretation and communication of medical science. In short: Precision dramatically accelerates your pathway from proof of concept to drug approval.

News & Insights
Thought Leadership

Precision Medicine Group is an integrated team of experts in fields from advanced lab sciences to translational informatics, clinical trial delivery, and regulatory affairs, payer insights to marketing communications. Together, we help our pharmaceutical and life-sciences clients conquer product development and commercialization challenges in a rapidly evolving environment.